Gabapentin enacarbil (GEn) improves restless legs syndrome

SAN DIEGO -- May 14, 2009 -- Gabapentin enacarbil (GEn) improves restless legs syndrome (RLS) while reducing associated pain, according to phase 3 results presented here at the 28th Annual Scientific Meeting of the American Pain Society (APS).Results, which were presented on May 9, showed that at week 12 last observation carried forward (LOCF), significantly more patients treated with GEn reported a more than 50% reduction in pain...

Click here to read full article